SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Dec-23 7:31 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 15-Dec-23 | Purchase | 23,000 | $5.86 | $134,734.00 | 41% 55.76K to 78.76K | |
18-Dec-23 7:31 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-23 | Option Exercise | 9,612 | -- | -- | 21% 46.15K to 55.76K | |
10-Jan-24 7:56 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 13-Dec-23 | Private Purchase | 38,803 | $5.21 | $202,036.00 | 49% 78.76K to 117.56K | |
12-Jul-23 7:36 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-23 | Option Exercise | 7,014 | -- | -- | 18% 39.13K to 46.15K | |
08-Jun-23 7:45 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 06-Jun-23 | Option Exercise | 12 | $4.53 | $54.36 | < 1% 44.12K to 44.13K | |
08-Jun-23 7:45 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 06-Jun-23 | Planned Option Sale | 12 | $16.37 | $196.41 | (< 1%) 44.13K to 44.12K | |
08-Jun-23 7:45 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 06-Jun-23 | Sale (Planned) | 4,988 | $16.37 | $81,641.70 | (11%) 44.12K to 39.13K | |
09-May-23 7:35 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 07-May-23 | Option Exercise | 4,988 | -- | -- | 13% 39.13K to 44.12K | |
02-May-23 10:00 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-May-23 | Option Exercise | 5,000 | $4.67 | $23,350.00 | 13% 39.13K to 44.13K | |
02-May-23 10:00 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-May-23 | Planned Option Sale | 5,000 | $17.92 | $89,600.50 | (11%) 44.13K to 39.13K | |
05-Apr-23 7:05 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Apr-23 | Option Exercise | 5,000 | $4.67 | $23,350.00 | 13% 39.13K to 44.13K | |
05-Apr-23 7:05 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Apr-23 | Planned Option Sale | 5,000 | $18.46 | $92,280.50 | (11%) 44.13K to 39.13K | |
03-Mar-23 10:00 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Mar-23 | Option Exercise | 5,000 | $4.67 | $23,350.00 | 13% 39.13K to 44.13K | |
03-Mar-23 10:00 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Mar-23 | Planned Option Sale | 5,000 | $16.59 | $82,971.00 | (11%) 44.13K to 39.13K | |
03-Feb-23 7:39 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Feb-23 | Option Exercise | 5,000 | $4.67 | $23,350.00 | 13% 39.13K to 44.13K | |
03-Feb-23 7:39 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Feb-23 | Planned Option Sale | 5,000 | $16.02 | $80,077.00 | (11%) 44.13K to 39.13K | |
13-Jan-23 8:03 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 12-Jan-23 | Option Exercise | 2,621 | $4.58 | $12,011.20 | 6% 41.51K to 44.13K | |
13-Jan-23 8:03 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 12-Jan-23 | Planned Option Sale | 2,621 | $16.00 | $41,936.00 | (6%) 44.13K to 41.51K | |
13-Jan-23 8:03 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 12-Jan-23 | Sale (Planned) | 2,379 | $16.00 | $38,064.00 | (6%) 41.51K to 39.13K | |
16-Dec-22 8:00 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-22 | Option Exercise | 4,632 | -- | -- | 13% 36.88K to 41.51K | |
06-Dec-22 7:40 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 02-Dec-22 | Option Exercise | 10,000 | $4.53 | $45,300.00 | 27% 36.88K to 46.88K | |
06-Dec-22 7:40 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 02-Dec-22 | Planned Option Sale | 10,000 | $16.11 | $161,122.00 | (21%) 46.88K to 36.88K | |
05-Oct-22 7:56 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Oct-22 | Option Exercise | 5,000 | $4.57 | $22,841.10 | 14% 36.88K to 41.88K | |
05-Oct-22 7:56 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Oct-22 | Planned Option Sale | 5,000 | $18.43 | $92,134.30 | (12%) 41.88K to 36.88K | |
02-Sep-22 7:50 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Sep-22 | Option Exercise | 2,987 | $4.53 | $13,531.10 | 8% 37.22K to 40.2K | |
02-Sep-22 7:50 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Sep-22 | Planned Option Sale | 2,987 | $17.12 | $51,127.50 | (7%) 40.2K to 37.22K | |
02-Sep-22 7:50 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Sep-22 | Sale (Planned) | 334 | $17.12 | $5,716.97 | (< 1%) 37.22K to 36.88K | |
02-Aug-22 8:15 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Aug-22 | Market Sale (Planned) | 5,000 | $19.40 | $96,979.00 | (12%) 42.22K to 37.22K | (16%) |
12-Jul-22 8:34 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 10-Jul-22 | Option Exercise | 7,014 | -- | -- | 20% 35.2K to 42.22K | |
06-Jul-22 8:01 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 05-Jul-22 | Option Exercise | 5,000 | $4.53 | $22,650.00 | 14% 35.2K to 40.2K | |
06-Jul-22 8:01 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 05-Jul-22 | Planned Option Sale | 5,000 | $16.03 | $80,157.00 | (12%) 40.2K to 35.2K | |
28-Jun-22 7:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 27-Jun-22 | Option Exercise | 3,802 | $4.67 | $17,755.30 | 10% 38.94K to 42.74K | |
28-Jun-22 7:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 27-Jun-22 | Planned Option Sale | 2,550 | $16.07 | $40,967.20 | (6%) 42.74K to 40.19K | |
28-Jun-22 7:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 27-Jun-22 | Sale (Planned) | 4,987 | $16.07 | $80,118.90 | (12%) 40.19K to 35.2K | |
28-Jun-22 7:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 24-Jun-22 | Option Exercise | 1,211 | $4.67 | $5,653.55 | 3% 40.19K to 41.4K | |
28-Jun-22 7:38 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 24-Jun-22 | Planned Option Sale | 2,463 | $16.02 | $39,454.00 | (6%) 41.4K to 38.94K | |
10-May-22 8:07 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 07-May-22 | Option Exercise | 4,988 | -- | -- | 14% 35.2K to 40.19K | |
05-Apr-22 7:43 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Apr-22 | Option Exercise | 5,000 | $4.67 | $23,350.00 | 14% 35.2K to 40.2K | |
05-Apr-22 7:43 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Apr-22 | Planned Option Sale | 5,000 | $21.21 | $106,064.00 | (12%) 40.2K to 35.2K | |
03-Mar-22 8:40 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Mar-22 | Option Exercise | 5,000 | $4.67 | $23,350.00 | 14% 35.2K to 40.2K | |
03-Mar-22 8:40 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Mar-22 | Planned Option Sale | 5,000 | $19.86 | $99,309.00 | (12%) 40.2K to 35.2K | |
03-Feb-22 8:15 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Feb-22 | Option Exercise | 5,000 | $4.62 | $23,122.90 | 14% 35.2K to 40.2K | |
03-Feb-22 8:15 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Feb-22 | Planned Option Sale | 5,000 | $18.81 | $94,029.10 | (12%) 40.2K to 35.2K | |
05-Jan-22 7:53 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Jan-22 | Option Exercise | 5,000 | $4.53 | $22,650.00 | 14% 35.2K to 40.2K | |
05-Jan-22 7:53 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 03-Jan-22 | Market Option Sale (Planned) | 5,000 | $27.53 | $137,644.00 | (12%) 40.2K to 35.2K | |
16-Dec-21 9:32 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 14-Dec-21 | Option Exercise | 2,379 | -- | -- | 7% 32.82K to 35.2K | |
03-Dec-21 7:12 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Dec-21 | Option Exercise | 5,000 | $4.53 | $22,650.00 | 15% 32.82K to 37.82K | |
03-Dec-21 7:12 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 01-Dec-21 | Market Option Sale (Planned) | 5,000 | $30.90 | $154,509.00 | (13%) 37.82K to 32.82K | |
17-Nov-21 7:29 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 15-Nov-21 | Option Exercise | 13 | $4.53 | $58.89 | < 1% 37.81K to 37.82K | |
17-Nov-21 7:29 PM View: | Peregrine Pharmaceuticals I... (CDMO) | 15-Nov-21 | Market Option Sale (Planned) | 13 | $32.47 | $422.07 | (< 1%) 37.82K to 37.81K |